Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s Alexion Pharmaceuticals ALXN Stock Holding History

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,200	Closed	-$344K	–	84
2020 Q4	$344K	Hold	2,200	–	–	0.09%	33
2020 Q3	$252K	Hold	2,200	–	–	0.08%	31
2020 Q2	$247K	Hold	2,200	–	–	0.1%	29
2020 Q1	$198K	Buy	+2,200	New	+$216K	0.11%	28

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's ALXN Position: Q1 2021 in Review

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 2,200 shares — an estimated $344K sold.

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in ALXN in Q1 2020 and held it in 4 quarters. The position peaked at $344K in Q4 2020. 753 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna sold 2,200 Alexion Pharmaceuticals shares in Q1 2021, an estimated $344K.
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in Alexion Pharmaceuticals in Q1 2020 and held it in 4 quarters.
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's Alexion Pharmaceuticals position peaked at $344K in Q4 2020.
753 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's 13F filing for Q1 2021, filed 2 Sep 2025.